ReaMetrix raises $2.1M to develop cell lines
ReaMetrix, a company that prepares cell lines that express certain proteins over others, has brought in $2.1 million in venture capital, according to a filing with the SEC. Based in San Carlos, Calif., it is backed by Baring Private Equity Asia, Sequoia Capital India and Mobius Venture Capital.
Next Story: How do you rid your iPhone of the malicious "Duh" worm?
Previous Story: HootSuite lets you schedule status updates on Facebook, LinkedIn, Twitter
About the Author, Camille Ricketts
Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.
